Bit harsh on Slikk, Grant62
Quoting share cash backing and NTA for a company which at this point does not have recurring revenues (and more importantly profitability) and using those figures to support an argument concerning share price is very dangerous indeed.
I've posted on SLX before and have been in and out with limited success but ATM and for some time purely trading stock IMO.
I'm as bullish as anyone , the report does read well indeed but Slikk is right still highly speculative.
Hard to trade this baby as very announcement sensitive, but logic suggests TA over FA for the forseeable future.
- Forums
- ASX - By Stock
- SLX
- sorry to whoever holds them.
sorry to whoever holds them., page-37
Featured News
Add SLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.53 |
Change
-0.030(0.66%) |
Mkt cap ! $1.074B |
Open | High | Low | Value | Volume |
$4.61 | $4.64 | $4.50 | $1.135M | 250.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 874 | $4.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.55 | 211 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 874 | 4.530 |
1 | 680 | 4.510 |
1 | 1640 | 4.500 |
2 | 1851 | 4.490 |
4 | 21239 | 4.480 |
Price($) | Vol. | No. |
---|---|---|
4.550 | 211 | 1 |
4.560 | 211 | 1 |
4.570 | 1851 | 2 |
4.580 | 1851 | 2 |
4.590 | 1851 | 2 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
SLX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online